Par Drugs & Chemicals Ltd Share Price (PAR)
as on
| Source : NSE
Par Drugs & Chemicals Ltd Stock Performance
as on August 22, 2025 at 4:01 PM IST
Day's High
₹96₹97.151.20%
Upside
52 Week's Low
52 Week's High
₹81.01₹348.45
15.61%
Downside
262.97%
Upside
| Market Stats | |
| Previous Close | ₹97.10 |
| Open | ₹96.50 |
| Volume | 2,305.00 |
| Upper Circuit | ₹99.04 |
| Lower Circuit | ₹95.15 |
| Day's Low | ₹96 |
| Day's High | ₹97.15 |
| 52 Week Low | ₹81.01 |
| 52 Week High | ₹348.45 |
| Returns % | |
| 1 Month Return | -15.89 % |
| 3 Month Return | -6 % |
| 1 Year Return | -59.21 % |
| 3 Year Return | -42.09 % |
| 5 Year Return | + 290.21 % |
Par Drugs & Chemicals Ltd Stock Fundamentals & Key Indicators
Check Par Drugs & Chemicals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹118.74 Cr
Return on Equity (ROE)
18.49
PE Ratio (TTM)
0Return on capital employed (ROCE)
25.01
Beta (LTM)
1.01
P/B Ratio
3.1
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
31.62
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Par Drugs & Chemicals Ltd Stock's Interest Amongst Investors
Par Drugs & Chemicals Ltd Financial Results
Get the annual and quarterly financial summary of Par Drugs & Chemicals Ltd, including revenue, profit, loss and more.
Par Drugs & Chemicals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Par Drugs & Chemicals Ltd.
Par Drugs & Chemicals Ltd Earnings Results
Par Drugs & Chemicals Ltd’s net profit jumped 31.62% since last year same period to ₹3.33Cr in the Q1 2025-2026. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 101.82% jump in its net profits since last 3-months.
Read More about Earnings ResultsPar Drugs & Chemicals Ltd Dividends November,2021
In the quarter ending September 2021, Par Drugs & Chemicals Ltd has declared dividend of ₹1.25 per share on 09 Nov 2021 - translating a dividend yield of 1.30%.
Read More about Dividends
Par Drugs & Chemicals Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Par Drugs & Chemicals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 73.37% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 26.63% | 0.00 | |
| Others | 0% | 0.00 |
Par Drugs & Chemicals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Par Drugs & Chemicals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 118.74 | 58.04% | 0.00 | 14 | 95 | |
| NA | 355.90 | -5.99% | 0.69 | 5 | 1,684 | |
| NA | 140.63 | 16.77% | 0.84 | 7 | 339 | |
| NA | 13.76 | -2.08% | 0.00 | -6 | 11 | |
| NA | 979.15 | 294.15% | 0.74 | 7 | 1 |
Par Drugs & Chemicals Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Par Drugs & Chemicals Ltd.
Par Drugs Reports Significant Profit Decline - 09 May, 2025
Par Drugs & Chemicals reported a 55.65% decline in standalone net profit to Rs 1.65 crore for Q1 FY2025, compared to Rs 3.72 crore in Q1 FY2024. Sales also fell by 2.15% to Rs 22.33 crore. For the full year, net profit decreased by 7.86% to Rs 13.36 crore, despite a 5.57% increase in annual sales to Rs 100.97 crore.
Insights on Par Drugs & Chemicals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 73.37% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 140.4% return, outperforming this stock by 182.4%
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 26.63% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 26.7% return, outperforming this stock by 85.9%
NEGATIVE IMPACTPrice Dip
In the last 7 days, PAR stock has moved down by -4.5%
About Par Drugs & Chemicals Ltd
Revenue: ₹26.05Cr as on June 2025 (Q1 FY26)
Net Profit: ₹3.33Cr as on June 2025 (Q1 FY26)
Listing date: 16 May, 2019
Chairperson Name: FALGUN VALLABHBHAI SAVANI
| Organisation | Par Drugs & Chemicals Ltd |
| Industry | Pharmaceuticals |
| CEO | FALGUN VALLABHBHAI SAVANI |
| E-voting on shares | Click here to vote |
FAQs
What is Par Drugs & Chemicals Ltd share price today?
Par Drugs & Chemicals Ltd share price today stands at ₹96, Open: ₹96.5, Previous Close: ₹97.1, High: ₹97.15, Low: ₹96, 52 Week High: ₹348.45, 52 Week Low: ₹81.01 as on .
How to buy Par Drugs & Chemicals Ltd shares ?
To buy Par Drugs & Chemicals Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for PAR or Par Drugs & Chemicals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Par Drugs & Chemicals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Par Drugs & Chemicals Ltd?
Today's traded volume of Par Drugs & Chemicals Ltd is 2,305.00. Which means that 2,305.00 shares of Par Drugs & Chemicals Ltd were bought and sold on the stock market during today's trading session.
What is Par Drugs & Chemicals Ltd's market cap today?
Today's market capitalisation of Par Drugs & Chemicals Ltd is ₹118.74 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Par Drugs & Chemicals Ltd?
Par Drugs & Chemicals Ltd’s 52 week high is ₹348.45 and 52 week low is ₹81.01. The current share price of Par Drugs & Chemicals Ltd is ₹96, which is -72.45% down from its 52 week high and 18.50% up from its 52 week low.